Back to News
Market Impact: 0.38

Knife River Corp stock hits 52-week low at 55.27 USD

Source: Investing.com

Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsInfrastructure & DefenseMarket Technicals & Flows
Knife River Corp stock hits 52-week low at 55.27 USD

Knife River shares reached a 52-week low near $55.27, down 25.88% over one year, after Q2 2026 EPS of $0.77 missed the $1.75 consensus estimate despite 13% revenue growth to $938.6 million. The company raised 2026 revenue guidance to $3.4 billion-$3.6 billion and reaffirmed adjusted EBITDA guidance of $520 million-$560 million, while backlog rose roughly $50 million sequentially. JPMorgan downgraded the stock to Underweight and cut its target to $73 from $80, citing constrained growth in Oregon, although DA Davidson initiated Buy coverage with an $85 target.

Analysis

KNF’s setup is not a simple oversold rebound: the key issue is whether its revenue growth is being purchased through lower-margin work, weather/fuel disruption, or unfavorable geographic mix. Maintaining EBITDA guidance after a large quarterly earnings miss makes second-half execution the only near-term valuation support; investors should demand evidence in gross margin, price/cost realization, and cash conversion rather than treat backlog growth as incremental profit. A higher-rate backdrop also raises the hurdle for public and private construction activity, particularly for non-residential and residential-adjacent aggregates demand.

The largest second-order risk is regional concentration. If Oregon infrastructure activity plateaus, KNF’s decentralized operating model may not offset fixed-cost absorption pressure quickly enough, creating downside to the market’s implied normalized EBITDA assumptions. This would also distinguish KNF from more geographically diversified materials peers such as MLM and VMC, whose scale and broader end-market exposure can sustain pricing and utilization through localized slowdowns. Conversely, a sustained federal/state infrastructure funding conversion into awarded projects could make current estimates too conservative, but that is more likely a 6-18 month catalyst than a next-quarter repair.

Consensus may overemphasize the technical low and third-party "fair value" signals. The relevant catalyst over the next 1-3 months is not RSI mean reversion but confirmation that second-half margins recover sufficiently to protect full-year EBITDA and that 2027 guidance does not reset lower. Until then, a low multiple can be a reflection of earnings-quality uncertainty rather than a bargain.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately negative

Sentiment Score

-0.42

Ticker Sentiment

JPM-0.20
KNF-0.78

Key Decisions for Investors

  • Maintain a tactical underweight/short bias in KNF into the next earnings or material guidance update; use a close above $62 without a corresponding EBITDA-guidance reduction as a risk stop. Downside case is a guidance reset and de-rating toward the low-$40s; upside risk is a clean margin recovery and infrastructure-driven order conversion.
  • For relative-value exposure, favor long VMC or MLM versus short KNF over 3-6 months, sized beta-neutral. The thesis is geographic diversification and better fixed-cost absorption; exit if KNF reports margin expansion ahead of peers for two consecutive quarters or Oregon demand materially reaccelerates.
  • Do not buy KNF solely on oversold technicals. Place an alert for quarterly adjusted EBITDA margin, operating cash flow conversion, and full-year EBITDA guidance: a reaffirmation accompanied by improving margin and cash conversion would justify reassessing a long after the next report.
  • Watch state DOT letting volumes and public-works bid activity in KNF’s core markets over the next 1-2 quarters. Evidence of accelerating funded-project conversion would falsify the regional-demand short thesis before reported earnings do.

More News

From AllMind Research

Browse all research